Note: Flagship Biosciences's revenues are gauged from an analysis of company filings.
Flagship Biosciences's Income Statement (based on Industry Averages)
Flagship Biosciences P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Flagship Biosciences has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
April 18, 2024
3
78%
$6 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Flagship Biosciences is developing and marketing.
Flagship Biosciences doesn't have any recent trademark applications, indicating Flagship Biosciences is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
SPATIALPLEX Scientific and technological services, namely, imaging and morphologically-guided investigation of human and animal tissues, investigating and interpreting biomarkers including DNA, RNA, amino acids, miRNA, epigenetic and biological data, all for the purpose of developing medical therapies
06/04/2021
TISSUEINSIGHT Consulting services in the fields of diagnostic medical testing and nutrition; Medical diagnostic testing, monitoring and reporting services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of oncology; Medical testing for diagnostic or treatment purposes in the field of pathology; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
12/14/2020
ACTIONANALYSIS Research and development and consultation related thereto in the field of pharmaceutical therapeutics, namely, scientific research and development of clinical, diagnostic, and analytical testing services
05/18/2018
See all trademarks and details in the Full Report.
Market Share of Flagship Biosciences's Largest Competitors
A competitive analysis shows these companies are in the same general field as Flagship Biosciences, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Flagship Biosciences.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Flagship Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.